Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 The Rise in Prevalence of Obesity Cases
4.2.2 I Increased Relucatance towards Surgical Procedures
4.3 Market Restraints
4.3.1 Less Awareness about Cellulite Treatment in Emerging Countries
4.3.2 Adoption of Substituent Traditional and Herbal Massage Therapies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 Procedure
5.1.1 Minimally Invasive
5.1.2 Non-Invasive
5.1.3 Topical
5.2 Cellulite
5.2.1 Soft Cellulite
5.2.2 Hard Cellulite
5.2.3 Edematous Cellulite
5.3 End-User
5.3.1 Hospitals
5.3.2 Cosmetic Surgery Centers
5.3.3 Specialized Dermatology Clinics
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Merz Pharma GmbH & Co KGaA
6.1.2 Inceler Medikal Co Ltd
6.1.3 Candela Corporation
6.1.4 Hologic Inc
6.1.5 Cutera Inc
6.1.6 Nestle S A
6.1.7 Tanceuticals LLC
6.1.8 Zimmer Aesthetics
6.1.9 cymedics GmbH & Co KG
6.1.10 Beijing Nubway S&T Co Ltd


7 MARKET OPPORTUNITIES AND FUTURE TRENDS